Startups
Albatroz Therapeutics is a pre-clinical stage biotechnology company with a mission to treat solid tumors and arthritic disorders that depend on extracellular matrix (ECM) remodeling.
Overview
Location
Singapore, Queenstown
Employees
11-50
Total raised
$3M
Founded date
2020
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 18, 2024 | PairX Bio Clinches Coveted Amgen Golden Ticket Award, as NSG BioLabs Deepens Efforts with Partners CapitaLand and Amgen to Boost Singapore's Biotech Ecosystem with Fourth Site and Extended Awards Programme | The Amgen Golden Ticket Award, now in its third year, showcases Amgen's and NSG BioLabs' efforts to support high-growth startups in a nurturing ecosystem, with a doubling of applicants compared to last year Amgen and NSG BioLabs extended th... |
| Jul 17, 2024 | PairX Bio Clinches Coveted Amgen Golden Ticket Award, as NSG BioLabs Deepens Efforts with Partners CapitaLand and Amgen to Boost Singapore's Biotech Ecosystem with Fourth Site and Extended Awards Programme | The Amgen Golden Ticket Award, now in its third year, showcases Amgen's and NSG BioLabs' efforts to support high-growth startups in a nurturing ecosystem, with a doubling of applicants compared to last year Amgen and NSG BioLabs extended th... |
| Apr 25, 2023 | Albatroz Therapeutics Raises $3M in Funding | Albatroz Therapeutics, a Singapore-based biotechnology company targeting tissue remodeling to stop cancer growth and treat arthritis, raised $3M in funding. The round was led by Outram Bio and SEEDS Capital. Christopher Tan, Partner at Outr... |
| Albatroz Therapeutics |
Reviews 0
FAQ about Albatroz Therapeutics
When was Albatroz Therapeutics founded?
Albatroz Therapeutics was founded in 2020.
How much funding has Albatroz Therapeutics raised?
Albatroz Therapeutics has raised $3M in total across 1 funding round.
What has the press written about Albatroz Therapeutics?
Parsers VC has collected 5 articles mentioning Albatroz Therapeutics, among them “PairX Bio Clinches Coveted Amgen Golden Ticket Award, as NSG BioLabs Deepens Efforts with Partners CapitaLand and Amgen to Boost Singapore's Biotech Ecosyste...” (Jul 18, 2024) and “PairX Bio Clinches Coveted Amgen Golden Ticket Award, as NSG BioLabs Deepens Efforts with Partners CapitaLand and Amgen to Boost Singapore's Biotech Ecosyste...” (Jul 17, 2024).
Is Albatroz Therapeutics still active?
Yes, Albatroz Therapeutics is active; its latest activity on Parsers VC dates from Jul 18, 2024.